 Susan Calcaterra
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 24 | 2024 | 480 | 8.810 |
Why?
| | Buprenorphine | 14 | 2024 | 160 | 6.110 |
Why?
| | Analgesics, Opioid | 33 | 2024 | 886 | 5.150 |
Why?
| | Methadone | 11 | 2024 | 89 | 3.800 |
Why?
| | Opiate Substitution Treatment | 11 | 2024 | 134 | 3.210 |
Why?
| | Addiction Medicine | 3 | 2024 | 9 | 2.410 |
Why?
| | Hospitalists | 5 | 2021 | 231 | 2.400 |
Why?
| | Hospitalization | 12 | 2024 | 2057 | 2.130 |
Why?
| | Substance Withdrawal Syndrome | 6 | 2023 | 171 | 1.810 |
Why?
| | Substance-Related Disorders | 7 | 2022 | 1010 | 1.430 |
Why?
| | Pain Management | 5 | 2024 | 317 | 1.320 |
Why?
| | Acute Pain | 4 | 2024 | 45 | 1.260 |
Why?
| | Medical Marijuana | 2 | 2020 | 106 | 1.170 |
Why?
| | Central Nervous System Stimulants | 3 | 2015 | 153 | 1.130 |
Why?
| | Patient Discharge | 6 | 2023 | 850 | 1.130 |
Why?
| | Qualitative Research | 7 | 2024 | 1224 | 1.070 |
Why?
| | Drug Overdose | 6 | 2019 | 319 | 1.000 |
Why?
| | Referral and Consultation | 4 | 2022 | 724 | 0.900 |
Why?
| | Amphetamine-Related Disorders | 1 | 2024 | 36 | 0.890 |
Why?
| | Chronic Pain | 6 | 2022 | 253 | 0.880 |
Why?
| | Methamphetamine | 1 | 2024 | 54 | 0.870 |
Why?
| | Practice Patterns, Physicians' | 9 | 2022 | 1260 | 0.870 |
Why?
| | Hospital Medicine | 3 | 2022 | 91 | 0.860 |
Why?
| | Hospitals | 6 | 2024 | 631 | 0.850 |
Why?
| | Cause of Death | 3 | 2013 | 392 | 0.780 |
Why?
| | Humans | 56 | 2024 | 128019 | 0.770 |
Why?
| | Benzodiazepines | 2 | 2022 | 130 | 0.730 |
Why?
| | Prisoners | 2 | 2014 | 141 | 0.700 |
Why?
| | Prescription Drug Misuse | 2 | 2018 | 39 | 0.690 |
Why?
| | Medicine | 1 | 2021 | 117 | 0.640 |
Why?
| | Drug Substitution | 1 | 2019 | 51 | 0.640 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 205 | 0.630 |
Why?
| | Adult | 25 | 2024 | 35176 | 0.610 |
Why?
| | Internationality | 1 | 2019 | 149 | 0.590 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1088 | 0.590 |
Why?
| | Healthcare Disparities | 1 | 2024 | 579 | 0.570 |
Why?
| | Health Services Accessibility | 2 | 2024 | 895 | 0.570 |
Why?
| | Physicians | 2 | 2024 | 858 | 0.560 |
Why?
| | Poison Control Centers | 1 | 2018 | 89 | 0.540 |
Why?
| | Burnout, Professional | 1 | 2022 | 407 | 0.520 |
Why?
| | Naloxone | 5 | 2020 | 110 | 0.520 |
Why?
| | Global Health | 1 | 2019 | 327 | 0.510 |
Why?
| | United States | 12 | 2024 | 13785 | 0.510 |
Why?
| | Marijuana Smoking | 1 | 2019 | 239 | 0.500 |
Why?
| | Cancer Survivors | 1 | 2020 | 263 | 0.490 |
Why?
| | Retrospective Studies | 15 | 2022 | 14404 | 0.480 |
Why?
| | Electronic Health Records | 3 | 2022 | 973 | 0.480 |
Why?
| | Narcotic Antagonists | 5 | 2021 | 160 | 0.470 |
Why?
| | Drug Users | 1 | 2015 | 41 | 0.460 |
Why?
| | Emergency Service, Hospital | 4 | 2023 | 1896 | 0.460 |
Why?
| | Perception | 1 | 2017 | 336 | 0.450 |
Why?
| | Middle Aged | 17 | 2024 | 30812 | 0.430 |
Why?
| | Cannabis | 1 | 2020 | 426 | 0.410 |
Why?
| | Alcoholism | 2 | 2023 | 764 | 0.410 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 746 | 0.400 |
Why?
| | Alcohol Drinking | 1 | 2019 | 751 | 0.400 |
Why?
| | Patient Satisfaction | 1 | 2017 | 624 | 0.400 |
Why?
| | Female | 23 | 2024 | 68016 | 0.380 |
Why?
| | Male | 23 | 2024 | 62757 | 0.380 |
Why?
| | Interviews as Topic | 3 | 2024 | 714 | 0.370 |
Why?
| | Databases, Factual | 3 | 2017 | 1264 | 0.370 |
Why?
| | Prescription Drugs | 1 | 2013 | 112 | 0.360 |
Why?
| | Pain | 1 | 2016 | 748 | 0.340 |
Why?
| | Cocaine | 1 | 2012 | 148 | 0.340 |
Why?
| | Mental Health Services | 1 | 2015 | 400 | 0.340 |
Why?
| | Young Adult | 9 | 2024 | 12281 | 0.330 |
Why?
| | Consensus | 3 | 2022 | 607 | 0.310 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 756 | 0.300 |
Why?
| | Internal Medicine | 2 | 2024 | 246 | 0.300 |
Why?
| | Adolescent | 9 | 2024 | 20158 | 0.270 |
Why?
| | Inappropriate Prescribing | 2 | 2017 | 52 | 0.260 |
Why?
| | Forecasting | 2 | 2018 | 355 | 0.260 |
Why?
| | Hepatitis C | 2 | 2024 | 234 | 0.250 |
Why?
| | Stress, Psychological | 1 | 2014 | 1060 | 0.250 |
Why?
| | Colorado | 5 | 2019 | 4369 | 0.240 |
Why?
| | Analgesics | 2 | 2017 | 163 | 0.230 |
Why?
| | Hospitals, Psychiatric | 1 | 2024 | 23 | 0.230 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5353 | 0.220 |
Why?
| | Narcotics | 1 | 2023 | 45 | 0.210 |
Why?
| | Internship and Residency | 2 | 2024 | 1043 | 0.210 |
Why?
| | Aftercare | 1 | 2023 | 206 | 0.190 |
Why?
| | Patients | 1 | 2023 | 167 | 0.190 |
Why?
| | Social Workers | 1 | 2021 | 39 | 0.190 |
Why?
| | Morpholines | 1 | 2022 | 122 | 0.180 |
Why?
| | Pharmacists | 2 | 2021 | 246 | 0.180 |
Why?
| | Communication Barriers | 1 | 2022 | 98 | 0.180 |
Why?
| | Cost-Benefit Analysis | 2 | 2023 | 567 | 0.180 |
Why?
| | Aged | 7 | 2024 | 21892 | 0.170 |
Why?
| | Prescriptions | 1 | 2020 | 65 | 0.170 |
Why?
| | Drug Administration Schedule | 3 | 2018 | 755 | 0.170 |
Why?
| | Social Stigma | 1 | 2021 | 116 | 0.170 |
Why?
| | Nausea | 1 | 2020 | 108 | 0.160 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 53 | 0.160 |
Why?
| | Time | 1 | 2018 | 75 | 0.150 |
Why?
| | Attitude | 1 | 2020 | 250 | 0.150 |
Why?
| | Safety-net Providers | 1 | 2019 | 108 | 0.140 |
Why?
| | Patient Preference | 2 | 2018 | 185 | 0.140 |
Why?
| | Terminology as Topic | 1 | 2019 | 199 | 0.140 |
Why?
| | Cohort Studies | 3 | 2018 | 5378 | 0.140 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2017 | 44 | 0.130 |
Why?
| | Regression Analysis | 1 | 2019 | 978 | 0.130 |
Why?
| | Quality of Life | 2 | 2020 | 2672 | 0.130 |
Why?
| | Counseling | 1 | 2020 | 382 | 0.130 |
Why?
| | Ambulatory Care | 1 | 2020 | 500 | 0.130 |
Why?
| | South Carolina | 1 | 2016 | 41 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 1943 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 166 | 0.130 |
Why?
| | Mental Disorders | 1 | 2024 | 1005 | 0.130 |
Why?
| | Survival Rate | 1 | 2020 | 1870 | 0.120 |
Why?
| | Prospective Studies | 2 | 2020 | 7035 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5034 | 0.120 |
Why?
| | Community Health Planning | 1 | 2015 | 42 | 0.120 |
Why?
| | General Practice | 1 | 2015 | 26 | 0.120 |
Why?
| | Primary Health Care | 3 | 2023 | 1639 | 0.120 |
Why?
| | Prognosis | 2 | 2020 | 3766 | 0.110 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 296 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 741 | 0.110 |
Why?
| | Unemployment | 1 | 2014 | 42 | 0.110 |
Why?
| | Drug Prescriptions | 1 | 2016 | 245 | 0.110 |
Why?
| | Inpatients | 1 | 2018 | 464 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2018 | 523 | 0.110 |
Why?
| | Community Health Services | 1 | 2015 | 226 | 0.100 |
Why?
| | Topography, Medical | 1 | 2013 | 11 | 0.100 |
Why?
| | Housing | 1 | 2014 | 130 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2024 | 1272 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 2016 | 311 | 0.100 |
Why?
| | Washington | 1 | 2012 | 148 | 0.100 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4853 | 0.090 |
Why?
| | Risk Factors | 3 | 2018 | 9696 | 0.090 |
Why?
| | Drug Interactions | 1 | 2012 | 361 | 0.090 |
Why?
| | Interpersonal Relations | 1 | 2014 | 388 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7029 | 0.080 |
Why?
| | Survival Analysis | 1 | 2012 | 1262 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 1194 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2020 | 5688 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2013 | 719 | 0.070 |
Why?
| | Time Factors | 2 | 2016 | 6479 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 6355 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2015 | 3324 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2008 | 192 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1689 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2008 | 539 | 0.060 |
Why?
| | Phenobarbital | 1 | 2023 | 18 | 0.050 |
Why?
| | Life Expectancy | 1 | 2023 | 60 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2003 | 162 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2003 | 128 | 0.050 |
Why?
| | Osteoarthritis | 1 | 2003 | 166 | 0.050 |
Why?
| | Logistic Models | 2 | 2016 | 1975 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 332 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2019 | 122 | 0.040 |
Why?
| | Medical Audit | 1 | 2017 | 77 | 0.030 |
Why?
| | Health Transition | 1 | 2016 | 7 | 0.030 |
Why?
| | Clinical Competence | 1 | 2024 | 1007 | 0.030 |
Why?
| | Prescription Drug Overuse | 1 | 2016 | 11 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 170 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3009 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 633 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2016 | 556 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2017 | 478 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 621 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 491 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 1018 | 0.030 |
Why?
| | Communication | 1 | 2018 | 838 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 872 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1492 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2015 | 733 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3223 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2008 | 181 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 755 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 388 | 0.010 |
Why?
| | Iodoacetates | 1 | 2003 | 3 | 0.010 |
Why?
| | Hindlimb | 1 | 2003 | 125 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2003 | 397 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 933 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 118 | 0.010 |
Why?
| | Acetaminophen | 1 | 2003 | 245 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2008 | 2508 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2598 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2703 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5199 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2003 | 10110 | 0.000 |
Why?
| | Animals | 1 | 2003 | 34487 | 0.000 |
Why?
|
|
Calcaterra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|